Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $0.4190 (-5.67%) ($0.4190 - $0.4190) on Wed. Apr. 6, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 10.49% (three month average) | RSI | 50 | Latest Price | $0.4190(-5.67%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | ANPC declines -2.2% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) GLD(79%) GDXJ(39%) OIH(39%) EWI(29%) MCHI(29%) | Factors Impacting ANPC price | ANPC will decline at least -5.245% in a week (0% probabilities). VIXM(-28%) ARKK(-12%) UNG(-11%) TBT(-10%) ARKG(-9%) | | | | | Relative Volatility | | | | Market Trend Strength | -5.245% (StdDev 10.49%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
Resistance Level | $0.47 | 5 Day Moving Average | $0.44(-4.77%) | 10 Day Moving Average | $0.44(-4.77%) | 20 Day Moving Average | $0.47(-10.85%) | To recent high | -67.9% | To recent low | 6.9% | Market Cap | $4m | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |